Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-026392

Options or other derivatives

  • SVP Research & Product Dev. acquired 116,524 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wu Hua SVP Research & Product Dev. 2021-10-22 Grant or award · Employee Stock Option (right to buy) +58,161 58,161 D: show line 1 in the form
Wu Hua SVP Research & Product Dev. 2021-10-22 Grant or award · Employee Stock Option (right to buy) +14,540 14,540 D: show line 2 in the form
Wu Hua SVP Research & Product Dev. 2021-10-22 Grant or award · Employee Stock Option (right to buy) +6,979 6,979 D: show line 3 in the form
Wu Hua SVP Research & Product Dev. 2021-10-22 Grant or award · Earnout Rights (Restricted Stock Units) +32,191 32,191 D: show line 4 in the form
Wu Hua SVP Research & Product Dev. 2021-10-22 Grant or award · Employee Stock Option (right to buy) +4,653 4,653 I: show line 5 in the form
Loading xslF345X03/ownership.xml…